Love Maharashtra? Then you wil love Marathikatta!
Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                    Movies   Aviation   Pharma   About Us   Feedback   Links

Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                    Movies   Aviation   Pharma   About Us   Feedback   Links
PHARMA - RESTLESS LEG SYNDROME

Restless leg syndrome could be messing up your sleep

Shaking your leg too often? Beware, RLS could be the culprit

BY OUR PHARMA CORRESPONDENT


 

 

23 June, 2005: Next time you feel you have disrupted sleep, you are unable to fall asleep or you get insufficient hours of sleep, beware you may be suffering from Restless Leg Syndrome.

Do you have an irresistible urge to shake your legs too often? If the answer is yes, it ain’t silly. You could be probably suffering from Restless Leg Syndrome, which is a chronic and disruptive neurological disorder. Though the condition is common, it is under-diagnosed and would impact sleep and other daily activities, Glaxo Smthkline reported on its web site citing a study published in Archives of Internal Medicine. 

Information on RLS was gathered from about 15,391 participants. Although 81 per cent of the respondents reported discussing their RLS symptoms with physicians, only 6.22 per cent reported that they were given a diagnosis of RLS. The respondents were asked about the frequency and nature of RLS symptoms, degree of related stress and about prior physician consultation.

Glaxo Smithkline Clinical Neurology director Nancy L Earl says the biggest problem is obtaining appropriate diagnosis and management. “Millions of people suffer from RLS yet some physicians may not connect certain physical and sensorimotor symptoms to RLS, resulting in a sizeable population that is not getting medical attention or diagnosis,” she said.

Apart from the irresistible urge to move the legs, RLS is characterized by uncomfortable or sometimes painful sensations in the legs often described as creeping-crawling, tingling, pulling or tightening. The study found that RLS frequency was more in female study population. Thirty per cent of the RLS patients were younger than 50.

More than 75% of the study population said they had some sleep-related symptom, while 55.5% said their day time activities were disturbed. The study found that RLS patients’ general quality of life was comparable with that of other chronic conditions such as Type 2 Diabetes and clinical depression. Poor circulation (18.3 percent), arthritis (14.3 percent) and back problems (12.7 percent) were the most common diagnoses reported, when RLS patients sought medical help.

An estimated 10% of the adults in US suffer from RLS. Although its exact cause is unknown, researchers believe Restless Legs Syndrome may be related to dopamine. Dopamine is a chemical that carries the signals between nerve cells that control body movement. When the dopamine system does not function properly, it may upset the normal communication of these signals. There are currently no specific tests for Restless Legs Syndrome. Diagnosis is primarily based on discussions, the use of a diagnostic screener, a review of your medical history, and a physical examination.

A drug for Parkinson's disease, Requip (ropinirole), was approved earlier this year for treating RLS. It is the first medicine the Food and Drug Administration has officially sanctioned for RLS. 

BY OUR PHARMA CORRESPONDENT

 

Pharma News Headlines

Cancer News

Cardiac News

US FDA News

Pharma industry news

LATEST UPDATES

Roche, Novartis lead on novel cancer therapies

US FDA grants fast track status for GSK’s HIV drug

Stem Cell Bill could be delayed in US

FDA warning on abortion drug Mifeprex (Mifepristone)

US FDA recalls Baxter’s intravenous pumps

US FDA grants tentative nod to Ranbaxy’s glimepiride

Lupin launches generic ceftriaxone in US

Hormonal contraceptives safe for long-term use: WHO

Abortion pill to carry 'black box' warning

Vaccines not linked to autism, say experts

Novartis acquires Bristol-Myers’ OTC business in US

Guidant alerts on flaw in pacemakers

Awareness on Medicare drug benefit scheme low in US

NIH review finds govt scientists having ties with pharma firms

US FDA to decide on Plan B morning-after pill by Sept 1

Painkiller patch Duragesic under US FDA probe over patients deaths

Legionnaire's disease outbreak in US hospital in New Rochelle 

Genepharm in pact with 3 Australian distributors 

UK has new generics reimbursement scheme 

Teva gets US FDA nod for mirtazapine anti-depressant 

US patent office rejects Pfizer’s Lipitor claims 

Aethlon Medical to start trials on HIV device in India 

Panel to decide fate of Advair, Serevent and Foradil asthma drugs 

Prohibitive costs mar cancer therapy 

FDA directs Palladone withdrawal

Blindness alert on impotence drugs  

Novartis files for breast cancer drug in US, Europe  

Merck readies for $10 billion Vioxx battle  

Speak up on menopause, campaign urges US women 

Direct-To-Consumer ads mislead patients: US Senator  

EU to decide on sops for developing kids drugs  

Zidovudine by Ranbaxy gets US FDA tentative nod

Parkinson's Disease therapy triggers gambling in some patients

Parkinson's Disease symptoms may be relieved by Azilect

Are obesity and diabetes just accelerated aging?

Reducing lung infection and inflammation due to Cystic Fibrosis

Viruses may help cure cancer by killing cancer cells

New product relieves tooth pain resulting from dental sensitivity 

Cervical Cancer detector may improve on Pap Smears

Dietary supplement capsule by Liqing banned in US

Cold Stone Creamery cake batter ice-creams recalled

Guidant defibrillator recall: US FDA makes three classifications

AIDS drug stavudine by Aurobindo Pharma gets tentative US FDA approval for PEPFAR

Gates Foundation donates for a good cause

Paxil CR resupply in US pharmacies announced by GlaxoSmithKline

Viagra users not at risk of blindness: Pfizer

Stem cell research gets boost from Li Ka-shing

BiDil heart failure drug for black patients approved

Restless leg syndrome could be messing up your sleep

Glaxo Smithkline in pact with IAVI to develop AIDS drug

Pfizer acquires Vicuron Pharma for $1.9 billion

German Remedies launches Fludara Oral

Ranbaxy acquires generic product portfolio from Efarmes

Sandoz files seven ANDAs of drugs going off-patent

Elder Pharma plans unit, brand acquisition

Novasite Pharma buys PsyCheNomicS

Chemokine gets US patent for novel cancer drug

Roche gets USFDA approval for oral Xeloda

Nectar Lifesciences plans Rs 90 crore IPO 

Glaxo inks co-promotion pact with Eisai for Paritec

Early Intervention required to Prevent Diabetes

AIDS drug ahoy!

Novartis launches AMD patient counselling programme

Nanobac Life Sciences, UCSF to study kidney stones 

Surface Logix commences phase I trial for PDE-5 inhibitor

Temasek sets up $112 million pharma JV

Contraceptive from Neem, courtesy DRDO  

US FDA to source anti-HIV drugs from Indian firms  

Chemists boycott Glaxo, Novartis products  

Maharashtra phases out nerve tissue-based rabies vaccine  

Last long, really long - new sex drug soon  

Johnson and Johnson demonstrates coronary stent safety

Novartis has better breast cancer treatment

Pfizer's investigational drug reduces tumor growth

New labeling for beta-blocker Coreg 

Glaxo applies for FDA approval for Flaurix

Investigational drug for Acute Bipolar Mania And Schizophrenia

Preclinical Data Support Link Between IL-9 and Airway Hyperresponsiveness Associated With Asthma

 

 

Latest updates    Contact Us - Feedback    About Us